Medicare is set to begin covering obesity medications, marking a significant policy shift that will expand access for millions of patients. This decision is expected to unlock a substantial new market for pharmaceutical giants like Novo Nordisk and Eli Lilly.
Medicare to Cover Obesity Drugs, Boosting Pharma Market Access
MedicareObesity DrugsPharmaceutical SectorHealthcare PolicyMarket Expansion
